• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECKMAN COULTER ACCESS THYROGLOBULIN REAGENT; SYSTEM,TEST,THYROGLOBULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECKMAN COULTER ACCESS THYROGLOBULIN REAGENT; SYSTEM,TEST,THYROGLOBULIN Back to Search Results
Catalog Number 33860
Device Problems High Test Results (2457); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Misdiagnosis (2159); No Known Impact Or Consequence To Patient (2692)
Event Date 04/17/2015
Event Type  Injury  
Event Description
The customer reported obtaining reproducible elevated thyroglobulin (access thyroglobulin) results for one (1) patient involving the laboratory's unicel dxi 800 access immunoassay system (serial number (b)(4)).The elevated access thyroglobulin results were discordant with the roche thyroglobulin result which was negative.Customer reported that the elevated thyroglobulin results were discordant with the patient clinical picture.The thyroid antibody (access thyroglobulin antibody ii) assay result for this patient was negative.The initial, elevated access thyroglobulin result was released from the laboratory.There was a report of a change in patient treatment associated with this event as the patient received radiology and nuclear medicine tests.System checks, quality controls (qc) and calibrations were performing within specifications at the time of the event.The patient's initial sample was collected in a seven (7) ml tube.The customer stated that the sample was centrifuged for ten (10) minutes at 3,500 rpm (revolutions per minute), at 32°c (celsius degree).There were no issues related to sample integrity reported by the customer.
 
Manufacturer Narrative
Pt gender and weight: the customer did not supply patient's date of birth or weight.Initial reporter: customer account telephone number is (b)(6).\a beckman coulter (bec) field service engineer (fse) was not dispatched for this event.There is no evidence that the access thyroglobulin reagent was returned for evaluation.In conclusion, the cause of the event cannot be determined with the available information.
 
Manufacturer Narrative
The customer provided one sample for interference testing by the beckman coulter (bec) complaint handling unit (chu).The patient sample was analyzed on the access 2 immunoassay system serial number (b)(4), and recovered with an access thyroglobulin result of 72.07 ng/ml.This result confirmed the result obtained by the customer.The access thyroglobulin normal reference range is 1.15 - 50.3 ng/ml.Interference testing, using a mix of different blockers, was performed.The blockers used in the interference testing consist of pool 1 (polymak 33, hbr-1) which is composed of animal derived antibodies and scavenger alp, a blocker related to alkaline phosphatase.The sample recovered above the assay reference range when tested with the scavenger alp with result of 75.75 ng/ml.The result of the interference testing using the pool 1 of animal derived antibodies significantly reduced the result to within the assay reference range as it recovered at 2.65 ng/ml.Per the thyroglobulin instructions for use (ifu) limitations of procedure: "for assays employing antibodies, the possibility exists for interference by heterophile antibodies in the patient sample.Patients who have been regularly exposed to animals or have received immunotherapy or diagnostic procedures utilizing immunoglobulins or immunoglobulin fragments may produce antibodies, e.G.Hama, that interfere with immunoassays.Additionally, other heterophile antibodies such as human anti-goat antibodies may be present in patient samples." in conclusion, the investigation demonstrated that heterophile interference which is listed in the access thyroglobulin limitations of procedure, is the cause of the falsely elevated thyroglobulin result.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCESS THYROGLOBULIN REAGENT
Type of Device
SYSTEM,TEST,THYROGLOBULIN
Manufacturer (Section D)
BECKMAN COULTER
1000 lake hazeltine drive
chaska 55318
Manufacturer (Section G)
BECKMAN COULTER
1000 lake hazeltine drive
chaska 55318
Manufacturer Contact
jeffrey koll
1000 lake hazeltine drive
chaska 55318
MDR Report Key4906234
MDR Text Key6836990
Report Number2122870-2015-00426
Device Sequence Number1
Product Code MSW
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
K031269
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,foreign,health profe
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 06/18/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/10/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2016
Device Catalogue Number33860
Device Lot Number430265
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/14/2015
Was Device Evaluated by Manufacturer? No
Date Device Manufactured09/01/2014
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age74 YR
-
-